Tumor-suppressive roles of PHLDA3 protein have been reported in several cancer cell lines including ESCC, osteosarcoma (OS), acute myeloid leukemia (AML), B-cell lymphoma, and prostate cancer [6,13,42]. Here, PHLDA3 is linked to acute myeloid leukemia.